270 related articles for article (PubMed ID: 21093116)
1. Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives.
Al-Said MS; Bashandy MS; Al-Qasoumi SI; Ghorab MM
Eur J Med Chem; 2011 Jan; 46(1):137-41. PubMed ID: 21093116
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of novel pyridine, thiophene and thiazole derivatives.
Ghorab MM; Al-Said MS
Arch Pharm Res; 2012 Jun; 35(6):965-73. PubMed ID: 22870805
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimicrobial activity of some novel hydrazide, benzochromenone, dihydropyridine, pyrrole, thiazole and thiophene derivatives.
Refat HM; Fadda AA
Eur J Med Chem; 2013; 70():419-26. PubMed ID: 24184775
[TBL] [Abstract][Full Text] [Related]
5. Novel thiophene derivatives with sulfonamide, isoxazole, benzothiazole, quinoline and anthracene moieties as potential anticancer agents.
Ghorab MM; Bashandy MS; Alsaid MS
Acta Pharm; 2014 Dec; 64(4):419-31. PubMed ID: 25531783
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Cytotoxic Evaluation of Pyran, Dihydropyridine and Thiophene Derivatives of 3-Acetylcoumarin.
Mohareb RM; Megally Abdo NY
Chem Pharm Bull (Tokyo); 2015; 63(9):678-87. PubMed ID: 26329861
[TBL] [Abstract][Full Text] [Related]
7. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
Ghorab MM; Shaaban MA; Refaat HM; Heiba HI; Ibrahim SS
Eur J Med Chem; 2012 Jul; 53():403-7. PubMed ID: 22583778
[TBL] [Abstract][Full Text] [Related]
8. Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents.
Ghorab MM; Alsaid MS; Al-Dosari MS; Ragab FA; Al-Mishari AA; Almoqbil AN
Acta Pharm; 2016 Jun; 66(2):155-71. PubMed ID: 27279061
[TBL] [Abstract][Full Text] [Related]
9. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
[TBL] [Abstract][Full Text] [Related]
10. Novel thiophenes, thienopyrimidines, and triazolothienopyrimidines for the evaluation of anticancer and augmentation effects of gamma-radiation.
Shaaban MA; Ghorab MM; Heiba HI; Kamel MM; Zaher NH; Mostafa MI
Arch Pharm (Weinheim); 2010 Jul; 343(7):404-10. PubMed ID: 20379969
[TBL] [Abstract][Full Text] [Related]
11. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation.
Ghorab MM; Ragab FA; Heiba HI; Nissan YM; Ghorab WM
Arch Pharm Res; 2012 Aug; 35(8):1335-46. PubMed ID: 22941476
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of novel indenopyridine derivatives.
Ghorab MM; Al-Said MS
Arch Pharm Res; 2012 Jun; 35(6):987-94. PubMed ID: 22870807
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of some new thiazole and thiophene derivatives.
Khalil AM; Berghot MA; Gouda MA
Eur J Med Chem; 2009 Nov; 44(11):4434-40. PubMed ID: 19581025
[TBL] [Abstract][Full Text] [Related]
14. Novel 4-aminoquinazoline derivatives as new leads for anticancer drug discovery.
Ghorab MM; Alsaid MS
Acta Pharm; 2015 Sep; 65(3):299-309. PubMed ID: 26431107
[TBL] [Abstract][Full Text] [Related]
15. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
[TBL] [Abstract][Full Text] [Related]
16. One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity.
Holla BS; Rao BS; Sarojini BK; Akberali PM
Eur J Med Chem; 2004 Sep; 39(9):777-83. PubMed ID: 15337290
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents.
Elmegeed GA; Khalil WK; Mohareb RM; Ahmed HH; Abd-Elhalim MM; Elsayed GH
Bioorg Med Chem; 2011 Nov; 19(22):6860-72. PubMed ID: 22000946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
